Hina Khan, Breast Cancer and neuropathic pain
Hina Khan Refuses To Lose Hope As She Suffers 'Crippling Pain' Amid Breast Cancer Treatment: 'Hum Ladenge'
Hina Khan, who is currently battling stage three breast cancer, has been enduring various side effects from her treatment. Despite the challenges, she continues to work and inspire her fans. Recently,
Hina Khan suffers from severe neuropathic pain amid battling with stage three cancer; writes 'hum kaam karenge, aur ladenge'
Hina Khan, who is presently battling stage three breast cancer, has experienced a number of treatment-related adverse effects. Despite the difficulties, Hina has persevered and served as an example to many.
WATCH: Hina Khan suffers crippling neuropathic pain amid Stage 3 breast cancer battle; says 'Hum kaam karenge, aur ladenge'
Hina Khan, who is currently battling stage three breast cancer, has been suffering from several other side effects of the treatment. Amidst this tough journey, Hina hasn't stopped working and has been an inspiration for many.
Hina Khan shares her struggles while attending an event with neuropathic pain amid cancer treatment, “kaam karenge, aur ladenge
Hina Khan recently opened up about her struggles of going through neuropathic pain while attending a event due to professional committments.
Hina Khan reveals about 'crippling' pain which makes it difficult to stand for more than a few minutes: Hum kaam karenge
Hina Khan recently penned a long note regarding her health update. The actor wrote about the neuropathic pain she endured while attending an event. She mentioned about how she stays committed to remain resilient despite the health challenges.
Hina Khan attends event, stands for 1.5 hours despite crippling neuropathic pain
Hina Khan showed remarkable resilience by fulfilling commitments despite severe neuropathic pain which makes standing continuously difficult for her. The event required her to stand for 1.5 hours.
Virios Therapeutics Transforms into Dogwood Therapeutics
Virios Therapeutics ( (VIRI) ) has issued an update. Virios Therapeutics, Inc. has merged with Sealbond Limited’s subsidiary, ...
Neuroscience News1d
Genetic Mapping Unlocks Path to Effective Chronic Pain Relief
Researchers have developed a comprehensive atlas that maps genetic activity in nerve cells linked to chronic pain, offering a ...
Managed Healthcare Executive1d
How Do Skeletal Muscle Relaxants Fit Into Pain Management?
A review of skeletal muscle relaxants shows that they don't work for pain from osteoarthritis, neuropathic pain and other ...
'Some Pills, Faith In Almighty...': Hina Khan Overcomes Neuropathic Pain To Fulfill Commitment At Event, Wears Shoes Under Saree (VIDEO)
Hina attended an event she had committed to months ago, wearing shoes under her saree despite the pain. She recalled ...
bovnews8h
A New Chapter for Virios (VIRI): Transforming into Dogwood Therapeutics
Halneuron®: This innovative treatment is currently in Phase 2b development as a non-opioid therapy for CINP. Notably, it has received FDA Fast Track designation. This designation is crucial, as it ...
Daily11d
Neuropathic Pain in Type 1 Diabetes: High Incidence Without Clinical Signs and Limited Relief from Medications, Study
While diabetic peripheral neuropathy (DPN) is a well-recognized complication, the specific characteristics and impact of ...